1. Home
  2. LMAT vs VCEL Comparison

LMAT vs VCEL Comparison

Compare LMAT & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$90.71

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.36

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMAT
VCEL
Founded
1983
1989
Country
US
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
LMAT
VCEL
Price
$90.71
$37.36
Analyst Decision
Buy
Strong Buy
Analyst Count
6
5
Target Price
$101.83
$57.50
AVG Volume (30 Days)
95.9K
362.4K
Earning Date
01-01-0001
04-03-2026
Dividend Yield
0.88%
N/A
EPS Growth
N/A
385.71
EPS
N/A
N/A
Revenue
N/A
$237,224,000.00
Revenue This Year
$15.17
$18.02
Revenue Next Year
$9.07
$18.52
P/E Ratio
$39.12
$151.69
Revenue Growth
N/A
20.10
52 Week Low
$71.42
$29.24
52 Week High
$105.55
$55.41

Technical Indicators

Market Signals
Indicator
LMAT
VCEL
Relative Strength Index (RSI) 65.77 53.53
Support Level $85.78 $33.30
Resistance Level $88.50 $36.56
Average True Range (ATR) 2.24 1.61
MACD 0.33 0.09
Stochastic Oscillator 100.00 88.18

Price Performance

Historical Comparison
LMAT
VCEL

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: